S100A4 and congenital rubella syndrome: Specifically, we are able to establish a mouse model of CRS for symptom assessment after anti-S100A4 drug treatment and collecte nasal mucosal biopsies at different time points for proteomic time-series evaluation of the natural variability in nasal mucosal tissue remodeling over time and local response to anti-S100A4 treatment in mice.